Papers
6
Total Citations
210
H-Index
6
About
Dr. Lars Hanker is a leading gynecologic oncologist whose research has fundamentally shaped the understanding and surgical management of borderline ovarian tumors (BOT) and minimally invasive gynecologic surgery. His landmark work, including the highly cited "Age-dependent differences in borderline ovarian tumours" (75 citations) and "Surgical staging and prognosis in serous borderline ovarian tumours" (42 citations), both stemming from the AGO ROBOT study, established critical age-related prognostic factors and demonstrated that incomplete surgical staging is a negative prognostic indicator in BOT. These contributions have directly influenced clinical guidelines for staging procedures. Dr. Hanker is also at the forefront of robotic surgery innovation, authoring the influential review "Robotic surgery in gynecology: is the future already here?" (40 citations) and conducting pivotal comparative studies on surgical outcomes and long-term patient satisfaction following robotic-assisted versus conventional laparoscopic hysterectomy. His work provides essential evidence for the adoption of robotic platforms like the da Vinci Xi, while his investigation into serum CA125 for BOT diagnosis (14 citations) further demonstrates his comprehensive approach to improving patient care through rigorous clinical research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Robotic surgery in gynecology: is the future already here?40 citations · 2022
- 4
- 5
- 6The Value of Serum CA125 in the Diagnosis of Borderline Tumors of the Ovary14 citations · 2015